OTC Asthma Treatment Stirs ACAAI Controversy
November 17, 2012 — November 17, 2012 — A proposal from FDA for an expansive approach to OTC drugs spurred the American College of Allergy, Asthma, and Immunology (ACAAI) to hold a symposium on the subject and to hotly debate the topic throughout the course of its annual meeting this week.
